Read More Pharma Industry News Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global… byPallavi MadhirajuMarch 20, 2024